Trial intelligence / Profile preview

Local zoledronate for improved fixation of uncemented hip prostheses

2016-004960-20Phase 2Completed

Sponsor
Region Östergötland
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of zoledronic acid in hip osteoarthritis (2 arms), sponsored by Region Östergötland. Primary endpoint: Acetabular cup migration (MTPM) at 2 years. Started Dec 2016; status: completed.

02

Drugs

zoledronic acid
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on 2016-004960-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004960-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call